Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Seibert

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 8, 2002
Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancersA T Koki, N K Khan, B M Woerner, et al.
The Biochemical Journal|July 21, 2001
A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitorsM C Walker, R G Kurumbail, J R Kiefer, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 1999
Synthesis and activity of sulfonamide-substituted 4,5-diaryl thiazoles as selective cyclooxygenase-2 inhibitorsJ S Carter, S Kramer, J J Talley, et al.
Cancer Research|May 1, 1983
Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude miceK Seibert, S M Shafie, T J Triche, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
Pharmacological analysis of cyclooxygenase-1 in inflammationC J Smith, Y Zhang, C M Koboldt, et al.
Cancer Research|November 4, 2000
Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 ratsC J Grubbs, R A Lubet, A T Koki, et al.
Journal of Medicinal Chemistry|May 5, 2000
N-[[(5-methyl-3-phenylisoxazol-4-yl)-phenyl]sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administrationJ J Talley, S R Bertenshaw, D L Brown, et al.
Journal of Medicinal Chemistry|May 23, 1997
1,2-Diarylpyrroles as potent and selective inhibitors of cyclooxygenase-2I K Khanna, R M Weier, Y Yu, et al.
Cancer Research|March 23, 2000
Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitorsJ L Masferrer, K M Leahy, A T Koki, et al.
Journal of Medicinal Chemistry|November 11, 1994
Selective cyclooxygenase inhibitors: novel 1,2-diarylcyclopentenes are potent and orally active COX-2 inhibitorsD B Reitz, J J Li, M B Norton, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 8, 2002
Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancersA T Koki, N K Khan, B M Woerner, et al.
The Biochemical Journal|July 21, 2001
A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitorsM C Walker, R G Kurumbail, J R Kiefer, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 1999
Synthesis and activity of sulfonamide-substituted 4,5-diaryl thiazoles as selective cyclooxygenase-2 inhibitorsJ S Carter, S Kramer, J J Talley, et al.
Cancer Research|May 1, 1983
Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude miceK Seibert, S M Shafie, T J Triche, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
Pharmacological analysis of cyclooxygenase-1 in inflammationC J Smith, Y Zhang, C M Koboldt, et al.
Cancer Research|November 4, 2000
Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 ratsC J Grubbs, R A Lubet, A T Koki, et al.
Journal of Medicinal Chemistry|May 5, 2000
N-[[(5-methyl-3-phenylisoxazol-4-yl)-phenyl]sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administrationJ J Talley, S R Bertenshaw, D L Brown, et al.
Journal of Medicinal Chemistry|May 23, 1997
1,2-Diarylpyrroles as potent and selective inhibitors of cyclooxygenase-2I K Khanna, R M Weier, Y Yu, et al.
Cancer Research|March 23, 2000
Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitorsJ L Masferrer, K M Leahy, A T Koki, et al.
Journal of Medicinal Chemistry|November 11, 1994
Selective cyclooxygenase inhibitors: novel 1,2-diarylcyclopentenes are potent and orally active COX-2 inhibitorsD B Reitz, J J Li, M B Norton, et al.
Pageof 9